Holocene Advisors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,084
Closed -$596K 839
2022
Q1
$596K Buy
1,084
+125
+13% +$75.5K ﹤0.01% 751
2021
Q4
$634K Sell
959
-322
-25% -$246K ﹤0.01% 749
2021
Q3
$1.08M Buy
+1,281
New +$1.3M 0.01% 665

Other funds holding CDLX

Holocene Advisors's CDLX Position: Q2 2022 in Review

Holocene Advisors sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 1,084 shares — an estimated $596K sold.

Holocene Advisors first reported a position in CDLX in Q3 2021 and held it in 3 quarters. The position peaked at $1.08M in Q3 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • Holocene Advisors reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • Holocene Advisors sold 1,084 Cardlytics shares in Q2 2022, an estimated $596K.
  • Holocene Advisors first reported a position in Cardlytics in Q3 2021 and held it in 3 quarters.
  • Holocene Advisors's Cardlytics position peaked at $1.08M in Q3 2021.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on Holocene Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.